Inventor
HOLLENBAUGH DIANE
US18 patents
⚠️ This page may combine multiple inventors who share the name “HOLLENBAUGH DIANE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBVIE BIOTHERAPEUTICS INC
5 patentsUS10023645B1Jul 17, 2018
Anti-CD40 antibodies
ABBVIE BIOTHERAPEUTICS INC5 citations81
US10519243B2Dec 31, 2019
Anti-CD40 antibodies
ABBVIE BIOTHERAPEUTICS INC1 citations70
US10400041B2Sep 3, 2019
Nucleic acid molecules encoding anti-CD40 antibodies
ABBVIE BIOTHERAPEUTICS INC1 citations70
US10844131B2Nov 24, 2020
Anti-CD40 antibody
ABBVIE BIOTHERAPEUTICS INC0 citations49
US10597460B2Mar 24, 2020
Anti-CD40 antibodies
ABBVIE BIOTHERAPEUTICS INC0 citations49
FIVE PRIME THERAPEUTICS INC
4 patentsUS7678890B2Mar 16, 2010
Compositions and methods of treating disease with FGFR fusion proteins
FIVE PRIME THERAPEUTICS INC67 citations97
US7982014B2Jul 19, 2011
FGFR3-IIIc fusion proteins
FIVE PRIME THERAPEUTICS INC24 citations91
US9192683B2Nov 24, 2015
Methods of treating disease with FGFR1 fusion proteins
FIVE PRIME THERAPEUTICS INC0 citations51
US9173957B2Nov 3, 2015
FGFR2 fusion proteins comprising C-terminal deletion mutants of FGFR2-IIIC
FIVE PRIME THERAPEUTICS INC0 citations51
BRISTOL MYERS SQUIBB CO
4 patentsUS6051228AApr 18, 2000
Antibodies against human CD40
BRISTOL MYERS SQUIBB CO202 citations97
US5540926AJul 30, 1996
Soluble and its use in B cell stimulation
BRISTOL MYERS SQUIBB CO96 citations96
US5945513AAug 31, 1999
Fusion proteins comprising gp39 and CD8
BRISTOL MYERS SQUIBB CO25 citations92
US6413514B1Jul 2, 2002
Methods of using antibodies against human CD40
BRISTOL MYERS SQUIBB CO35 citations91